Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/28/09 → 9/27/12 |
Funding
- Quintiles, Inc. (BCX1812-303 // BCX1812-303)
- Biocryst Pharmaceuticals, Inc. (BCX1812-303 // BCX1812-303)
Prot # BCX1812-303: A Phase 3, Open-Label, Randomized Study of the Antiviral Activity, Safety, and Tolerability of Intravenous Peramivir in Adult and Adolescent Hospitalized Subjects with Confirmed or Suspected Influenza Infection
- Ison, Michael G (PD/PI)
Project: Research project